UAB Researchers Use CRISPR Technology to Target Childhood Syndrome
In the last couple of years there’s been a bonanza in life sciences around something called CRISPR. This is a process that bacteria do naturally as a defense mechanism, but scientists have figured out how to use it to snip out specific genes from DNA and replace them. In other words, it makes cheaper and more precise genetic editing possible.
“This kind of CRISPR technology that many people are practicing now is going to change the whole field of medicine,” says Tim Townes, director of the UAB Stem Cell Institute.
Townes led a team that published a paper Thursday in Cell Reports on their use of CRISPR to develop a potential new cure for a troubling condition in children. It’s called severe combined immunodeficiency or SCID. Children born with SCID have no immune response so they can’t fight invading viruses or bacteria. It’s more popularly know as the “bubble boy” syndrome. The only current treatment is a bone marrow transplant. Otherwise SCID is fatal.
Townes received skin cells from a patient who was successfully cured through a bone marrow transplant. His team then changed those cells to stem cells and used the CRISPR technique to change the one DNA base pair that causes SCID. The idea is that those cells would then be converted to blood stem cells and transplanted back into the patient, curing him or her.
“So they would be getting their own cells. But those cells would be corrected,” said Townes.
The Food and Drug Administration hasn’t allowed any studies on people using CRISPR yet, but Townes expects UAB to start clinical trials on the SCID therapy within two years.
While CRISPR has the potential to revolutionize biology, from curing genetic diseases to creating mosquitos that can’t carry malaria, it comes with weighty ethical concerns. Scientists and bioethicists are already warning about unintended consequences from changed genes, particularly if they are passed on to children. Also, CRISPR could theoretically be used to by parents to create “designer babies,” genetically engineered for desirable traits.
Scientists in China prompted an uproar earlier this year when they announced they used CRISPR to alter genes in human embryos.
Townes said they check carefully they only change the base pair targeted. He also says they’re only interested in curing disease.
“Any technology can be used for good or not so good purposes,” said Townes. “We want to develop new technology and it’s up to society as a whole to apply them in the correct way.”
Extra: Radiolab explains CRISPR
India and China to resume direct flights after a 5-year suspension
The suspension, which began with the 2020 Covid outbreak, was prolonged by tensions along the Himalayan border.
On ‘The Life of a Showgirl,’ Taylor Swift feels love’s glow and the spotlight’s glare
On her 12th album, the most dominant pop star of our era makes a spectacle of herself in full flower, in love and holding the music industry in the palm of her hand.
FDA approves another generic abortion pill, prompting outrage from conservatives
Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.
As the shutdown drags on, the threat of permanent cuts is mired in politics
President Trump is meeting with his budget director, Russ Vought, about what additional cuts to make during the shutdown, and the president says his targets are partisan.
Pope Leo’s religious community is drawing renewed interest. Here’s what makes it unique
"Before, we might get two or three discerners. But after Pope Leo, I now have 15. It's unbelievable."
The CDC still hasn’t issued COVID vaccine guidelines, leaving access in limbo
Access to the COVID-19 vaccines remains difficult because of an unusual and unexplained delay by the Centers for Disease Control and Prevention in accepting recommendations from its advisers.
